Fasting and Postprandial Plasma Citrulline and the Correlation to Intestinal Function Evaluated by 72-Hour Metabolic Balance Studies in Short Bowel Jejunostomy Patients With Intestinal Failure-Reference-Cited by-同舟云学术

Fasting and Postprandial Plasma Citrulline and the Correlation to Intestinal Function Evaluated by 72-Hour Metabolic Balance Studies in Short Bowel Jejunostomy Patients With Intestinal Failure

Published:2017-01-05 Issue: Volume: Page:014860711668749
ISSN:0148-6071
Container-title:Journal of Parenteral and Enteral Nutrition
language:en
Short-container-title:JPEN J Parenter Enteral Nutr

Author:

Fjermestad Hilde¹,Hvistendahl Mark¹,Jeppesen Palle Bekker¹

Affiliation:

1. Department of Medical Gastroenterology CA 2121, Rigshospitalet, Copenhagen, Denmark

Publisher

Wiley

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://journals.sagepub.com/doi/pdf/10.1177/0148607116687497

Reference23 articles.

1. Short Bowel Syndrome and Intestinal Failure: Consensus Definitions and Overview

2. AGA technical review on short bowel syndrome and intestinal transplantation

3. Intestinal Rehabilitation and the Short Bowel Syndrome: Part 1

4. Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome

5. Intestinal failure defined by measurements of intestinal energy and wet weight absorption

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translating plasma citrulline concentration in clinical practice: Role of cross-sectional assessment in adult patients with short bowel syndrome;Digestive and Liver Disease;2024-08

2. Correlates of Plasma Citrulline, a Potential Marker of Enterocyte Mass, among Children with Stunting: A Cross-Sectional Study in Uganda;The Journal of Nutrition;2023-12

3. Small bowel transplant – novel indications and recent progress;Expert Review of Gastroenterology & Hepatology;2023-06-05

4. Effects of glepaglutide, a long‐acting glucagon‐like peptide‐2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial;Journal of Parenteral and Enteral Nutrition;2022-05-31

5. Bile acid–farnesoid X receptor–fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trial;Journal of Parenteral and Enteral Nutrition;2021-09